DK2337573T3 - Valle til anvendelse i behandling af lymfocytopeni - Google Patents

Valle til anvendelse i behandling af lymfocytopeni

Info

Publication number
DK2337573T3
DK2337573T3 DK09782971.7T DK09782971T DK2337573T3 DK 2337573 T3 DK2337573 T3 DK 2337573T3 DK 09782971 T DK09782971 T DK 09782971T DK 2337573 T3 DK2337573 T3 DK 2337573T3
Authority
DK
Denmark
Prior art keywords
lymphocytopenia
wheels
treatment
Prior art date
Application number
DK09782971.7T
Other languages
English (en)
Inventor
Karine Vidal
Eric Delpierre
Cecile Loi
Christophe Moinard
Christine Charrueau
Denis Breuille
Luc Cynober
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of DK2337573T3 publication Critical patent/DK2337573T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
DK09782971.7T 2008-09-19 2009-09-14 Valle til anvendelse i behandling af lymfocytopeni DK2337573T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08105395A EP2165713B1 (en) 2008-09-19 2008-09-19 Whey and thymus function
PCT/EP2009/061876 WO2010031744A1 (en) 2008-09-19 2009-09-14 Whey and thymus function

Publications (1)

Publication Number Publication Date
DK2337573T3 true DK2337573T3 (da) 2014-01-20

Family

ID=40342721

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09782971.7T DK2337573T3 (da) 2008-09-19 2009-09-14 Valle til anvendelse i behandling af lymfocytopeni

Country Status (14)

Country Link
US (1) US8409592B2 (da)
EP (2) EP2165713B1 (da)
JP (1) JP2012502945A (da)
CN (1) CN102186494A (da)
AU (1) AU2009294704A1 (da)
BR (1) BRPI0919319A2 (da)
CA (1) CA2737771A1 (da)
DK (1) DK2337573T3 (da)
ES (1) ES2443965T3 (da)
MX (1) MX2011002980A (da)
PT (1) PT2337573E (da)
RU (1) RU2011115185A (da)
WO (1) WO2010031744A1 (da)
ZA (1) ZA201102911B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5377202B2 (ja) * 2009-09-29 2013-12-25 テルモ株式会社 栄養強化用食品素材
JP5377203B2 (ja) * 2009-09-30 2013-12-25 テルモ株式会社 術後補助食
WO2012057636A1 (en) * 2010-10-27 2012-05-03 Fonterra Corporate Research And Development Limited Modulation of th1 and th2 immune response by lactic acid whey
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP7266581B2 (ja) 2017-08-14 2023-04-28 アクセラ・ヘルス・インコーポレイテッド 肝疾患の治療のためのアミノ酸組成物
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1295557A1 (ru) * 1984-06-05 1989-03-30 Кубанский государственный университет Способ получени пептидной фракции кумыса,обладающей иммуностимулирующим действием
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
FI892006A (fi) * 1988-04-29 1989-10-30 Phil Gold Lactalbumin saosom tillaeggsaemne i mat.
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
FR2711529B1 (fr) 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
AU692612B2 (en) * 1994-10-14 1998-06-11 Morinaga Milk Industry Company Limited Peptide mixture and products thereof
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
ES2195555T3 (es) * 1998-03-31 2003-12-01 Nestle Sa Empleo de composiciones para proporcionar glutamina.
EP1094824B1 (en) * 1998-06-10 2006-04-05 Albert B. Crum Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
DE19856789A1 (de) * 1998-12-09 2000-06-15 Nutricia Nv Thymuswachstumsstimulierende Säuglingsnahrung
ATE303077T1 (de) * 1999-04-29 2005-09-15 Nestle Sa Süssmolkeprotein enthaltende säuglingsnahrung
US6833350B2 (en) * 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
SK12772003A3 (sk) * 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
BR0210680A (pt) * 2001-07-18 2004-09-21 Dsm Ip Assets Bv Processo para a hidrólise de proteìnas do leite
CA2532473C (en) 2003-06-23 2013-08-06 Nestec S.A. Amino acid supplementation for a healthy microbiota ecosystem
EP1811867A2 (en) * 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
ES2333814T3 (es) * 2005-02-09 2010-03-01 Vifor (International) Ag Uso de compuestos de complejo de hierro (iii).
CN100542430C (zh) * 2007-05-21 2009-09-23 北京东方兴企食品工业技术有限公司 一种含有益生菌的营养蛋白粉

Also Published As

Publication number Publication date
BRPI0919319A2 (pt) 2015-12-29
ES2443965T3 (es) 2014-02-21
EP2165713B1 (en) 2012-11-14
EP2337573B1 (en) 2013-12-25
AU2009294704A1 (en) 2010-03-25
WO2010031744A1 (en) 2010-03-25
US8409592B2 (en) 2013-04-02
EP2165713A1 (en) 2010-03-24
JP2012502945A (ja) 2012-02-02
RU2011115185A (ru) 2012-10-27
PT2337573E (pt) 2014-01-09
US20120039944A1 (en) 2012-02-16
ZA201102911B (en) 2012-09-26
CA2737771A1 (en) 2010-03-25
CN102186494A (zh) 2011-09-14
EP2337573A1 (en) 2011-06-29
MX2011002980A (es) 2011-05-10

Similar Documents

Publication Publication Date Title
LTC2330892I2 (lt) Gydymo būdai panaudojant vaistus - amoniako gaudykles
BRPI0910259A2 (pt) métodos de tratamento de inflamação
DK2350096T3 (da) Fremgangsmåder til behandling af hepatisk encephalopati
DK2894165T3 (da) Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser
BR112012001325A2 (pt) tratamento de distúrbios do fígado com inibidaores de pi3k
BRPI0910854A2 (pt) métodos de tratamento
DK2252342T3 (da) Indretninger og fremgangsmåder til behandling af skadet væv
DK3150240T3 (da) Systemer og fremgangsmåder til fremføring af terapeutiske midler
DK2365802T3 (da) Mikrokapsler af rapamycin og anvendelse til behandling af cancer
DK2417262T3 (da) Nanopartikelmedieret tilførsel af sekvensspecifikke nukleaser
BRPI0908276A2 (pt) Métodos de tratar dor inflamatória
DK2485751T3 (da) GLYX-13 til anvendelse i en fremgangsmåde til behandling af upåvirkelig depression
BRPI0917017A2 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
DK3412687T3 (da) Fremgangsmåder til behandling af dlbcl
DE502009000291D1 (de) Straßenfertiger und Verfahren
DK2350116T3 (da) Behandling af biofilm
DK2470202T3 (da) Clostridium-neurotoksiner til anvendelse i behandling af præmatur ejakulation
DK2344146T3 (da) Anticonnexin-midler til anvendelse til modulering af psykotrope molekylers terapeutiske virkning
DK2330887T3 (da) Behandlingsindretning
BRPI0917684A2 (pt) método terapêutico homeopático
DK2408807T3 (da) Fremgangsmåde til terapeutisk anvendelse
BRPI0908715A2 (pt) métodos para tratamento da psoríase
DK2337573T3 (da) Valle til anvendelse i behandling af lymfocytopeni
DK2297106T3 (da) Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande
DK2554172T3 (da) Fremgangsmåde til behandling af sygdomme